A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -43.70% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -58.97%. Over the past 30 days, the price of SXTP has leaped by -42.81%. And in the last five days, it has fallen by -18.78%.
60 Degrees Pharmaceuticals Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $7.20 on 07/19/24, while the lowest value for the same period was recorded at $0.70 on 01/31/25.
52-week price history of SXTP Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. 60 Degrees Pharmaceuticals Inc’s current trading price is -89.91% away from its 52-week high, while its distance from the 52-week low is 3.54%. The stock’s price range during this period has varied between$0.70 and $7.20. The 60 Degrees Pharmaceuticals Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.33 million for the day, a figure considerably lower than their average daily volume of 1.66 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
60 Degrees Pharmaceuticals Inc (SXTP) has experienced a quarterly rise of 0.60% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.67M and boasts a workforce of 3 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.1151, with a change in price of -0.6337. Similarly, 60 Degrees Pharmaceuticals Inc recorded 1,059,499 in trading volume during the last 100 days, posting a change of -46.60%.
SXTP’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for SXTP stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.02.
SXTP Stock Stochastic Average
60 Degrees Pharmaceuticals Inc’s raw stochastic average for the past 50 days is presently 1.47%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 2.92%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 15.09% and 15.62%, respectively.
